The Two Sigma Advisers LP Buys New Stake in Stericycle Inc. (SRCL)

The Two Sigma Advisers LP Buys New Stake in Stericycle Inc. (SRCL)

Two Sigma Advisers LP bought a new position in shares of Stericycle Inc. (NASDAQ:SRCL) during the third quarter, Holdings Channel reports. The institutional investor bought 263,616 shares of the company’s stock, valued at approximately $21,126,000. Two Sigma Advisers LP owned approximately 0.31% of Stericycle as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. Generation Investment Management LLP bought a new stake in shares of Stericycle during the second quarter valued at approximately $237,333,000. Fairpointe Capital LLC bought a new stake in shares of Stericycle during the second quarter valued at approximately $65,273,000. Global Thematic Partners LLC bought a new stake in shares of Stericycle during the second quarter valued at approximately $64,228,000. Pictet Asset Management Ltd. increased its stake in shares of Stericycle by 328.9% in the second quarter. Pictet Asset Management Ltd. now owns 687,021 shares of the company’s stock valued at $67,321,000 after buying an additional 526,835 shares during the period. Finally, Fort Washington Investment Advisors Inc OH purchased a new position in shares of Stericycle during the second quarter worth about $52,821,000. 92.48% of the stock is owned by institutional investors and hedge funds.

Stericycle Inc. (NASDAQ:SRCL) opened at 80.51 on Thursday. The stock has a market cap of $6.85 billion, a price-to-earnings ratio of 29.27 and a beta of 0.13. The firm’s 50-day moving average price is $76.48 and its 200-day moving average price is $82.53. Stericycle Inc. has a 12-month low of $71.52 and a 12-month high of $128.94.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings results on Thursday, October 27th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.17 by $0.07. The firm had revenue of $890.10 million for the quarter, compared to the consensus estimate of $899.87 million. Stericycle had a return on equity of 15.33% and a net margin of 7.52%. The company’s quarterly revenue was up 23.9% on a year-over-year basis. During the same period in the prior year, the company posted $1.08 earnings per share. On average, equities analysts predict that Stericycle Inc. will post $4.74 EPS for the current fiscal year.

A number of brokerages recently issued reports on SRCL. Zacks Investment Research upgraded Stericycle from a “strong sell” rating to a “hold” rating in a report on Wednesday, September 28th. Robert W. Baird lowered their target price on Stericycle from $99.00 to $85.00 and set a “neutral” rating on the stock in a research note on Friday, September 23rd. Wedbush lowered their target price on Stericycle from $95.00 to $85.00 and set a “neutral” rating on the stock in a research note on Thursday, September 22nd. Barrington Research reiterated an “outperform” rating and set a $88.00 target price (down from $100.00) on shares of Stericycle in a research note on Wednesday, October 5th. Finally, Goldman Sachs Group Inc. cut Stericycle from a “neutral” rating to a “sell” rating and set a $60.00 target price on the stock. in a research note on Thursday, November 3rd. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $92.75.

In other news, Director Mark C. Miller sold 6,677 shares of the company’s stock in a transaction on Tuesday, December 13th. The stock was sold at an average price of $76.23, for a total transaction of $508,987.71. Following the transaction, the director now directly owns 216,126 shares of the company’s stock, valued at $16,475,284.98. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 3.30% of the company’s stock.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc. (NASDAQ:SRCL).

Related posts

Leave a Comment